["{\n\"step_by_step_thinking\": \"The question is about ACE inhibitors and ARBs. Since the provided documents are related to ACE inhibitors and angiotensin-converting enzyme (ACE), we can conclude that there is no direct information about ARBs. Therefore, we will focus on ACE inhibitors. There is no mention of COVID-19 or severe cases in the provided documents. The documents discuss various aspects of ACE inhibitors, such as their pharmacological differences with angiotensin II antagonists, renal protection, and cardioprotective effects.\",\n\"answer_choice\": \"B\"\n}"]